These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29156807)

  • 21. [Regulatory effect of compound Coptidis Rhizoma capsule on unbalanced expression of renal tissue TGF-β1/BMP-7 and Smad signaling pathway in rats with early diabetic nephropathy].
    Liu S; Chen XQ; Tang LQ; Yu N; Zhang XL; Du HF
    Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(5):938-45. PubMed ID: 26087560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptional regulation of Smad2 is required for enhancement of TGFbeta/Smad signaling by TGFbeta inducible early gene.
    Johnsen SA; Subramaniam M; Katagiri T; Janknecht R; Spelsberg TC
    J Cell Biochem; 2002; 87(2):233-41. PubMed ID: 12244575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Halofuginone prevents extracellular matrix deposition in diabetic nephropathy.
    Sato S; Kawamura H; Takemoto M; Maezawa Y; Fujimoto M; Shimoyama T; Koshizaka M; Tsurutani Y; Watanabe A; Ueda S; Halevi K; Saito Y; Yokote K
    Biochem Biophys Res Commun; 2009 Feb; 379(2):411-6. PubMed ID: 19114027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model.
    Assis PA; De Figueiredo-Pontes LL; Lima AS; Leão V; Cândido LA; Pintão CT; Garcia AB; Saggioro FP; Panepucci RA; Chahud F; Nagler A; Falcão RP; Rego EM
    J Exp Clin Cancer Res; 2015 Jun; 34(1):65. PubMed ID: 26099922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of BMP and of TGFβ receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death.
    Augeri DJ; Langenfeld E; Castle M; Gilleran JA; Langenfeld J
    Mol Cancer; 2016 Apr; 15():27. PubMed ID: 27048361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone morphogenetic protein activities are enhanced by 3',5'-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells.
    Sugama R; Koike T; Imai Y; Nomura-Furuwatari C; Takaoka K
    Bone; 2006 Feb; 38(2):206-14. PubMed ID: 16203197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Connective tissue growth factor is a Smad2 regulated amplifier of transforming growth factor beta actions in hepatocytes--but without modulating bone morphogenetic protein 7 signaling.
    Gressner OA; Lahme B; Siluschek M; Rehbein K; Weiskirchen R; Gressner AM
    Hepatology; 2009 Jun; 49(6):2021-30. PubMed ID: 19309720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma.
    Wordinger RJ; Fleenor DL; Hellberg PE; Pang IH; Tovar TO; Zode GS; Fuller JA; Clark AF
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1191-200. PubMed ID: 17325163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone morphogenetic protein-7 inhibits silica-induced pulmonary fibrosis in rats.
    Yang G; Zhu Z; Wang Y; Gao A; Niu P; Tian L
    Toxicol Lett; 2013 Jul; 220(2):103-8. PubMed ID: 23639248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
    Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
    Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human stromal cells are required for an anti-breast cancer effect of zoledronic acid.
    Nienhuis HH; Arjaans M; Timmer-Bosscha H; de Vries EG; Schröder CP
    Oncotarget; 2015 Sep; 6(27):24436-47. PubMed ID: 26203666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor beta signaling through Smad1 in human breast cancer cells.
    Liu X; Yue J; Frey RS; Zhu Q; Mulder KM
    Cancer Res; 1998 Oct; 58(20):4752-7. PubMed ID: 9788633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PI3K/Akt-dependent transcriptional regulation and activation of BMP-2-Smad signaling by NF-kappaB in metastatic prostate cancer cells.
    Graham TR; Odero-Marah VA; Chung LW; Agrawal KC; Davis R; Abdel-Mageed AB
    Prostate; 2009 Feb; 69(2):168-80. PubMed ID: 18942118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coculture with prostate cancer cells alters endoglin expression and attenuates transforming growth factor-beta signaling in reactive bone marrow stromal cells.
    O'Connor JC; Farach-Carson MC; Schneider CJ; Carson DD
    Mol Cancer Res; 2007 Jun; 5(6):585-603. PubMed ID: 17579118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.
    Feeley BT; Krenek L; Liu N; Hsu WK; Gamradt SC; Schwarz EM; Huard J; Lieberman JR
    Bone; 2006 Feb; 38(2):154-66. PubMed ID: 16126463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PTHrP expression in chick sternal chondrocytes is regulated by TGF-beta through Smad-mediated signaling.
    Pateder DB; Ferguson CM; Ionescu AM; Schwarz EM; Rosier RN; Puzas JE; O'Keefe RJ
    J Cell Physiol; 2001 Sep; 188(3):343-51. PubMed ID: 11473361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming growth factor-β signaling induced during prostate cancer cell death and neuroendocrine differentiation is mediated by bone marrow stromal cells.
    Miles FL; Kurtoglu S; Ahmer C; Soori M; Favate JS; Sikes RA
    Prostate; 2015 Nov; 75(15):1802-13. PubMed ID: 26392321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BMP signaling inhibition overcomes chemoresistance of prostate cancer.
    Xie C; Wang Z; Ba Y; Aguilar J; Kyan A; Zhong L; Hao J
    Am J Cancer Res; 2023; 13(9):4073-4086. PubMed ID: 37818054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Bone Morphogenetic Protein Signaling Inhibitor LDN-193189 Enhances Metastasis Development in Mice.
    Vollaire J; Machuca-Gayet I; Lavaud J; Bellanger A; Bouazza L; El Moghrabi S; Treilleux I; Coll JL; Peyruchaud O; Josserand V; Cohen PA
    Front Pharmacol; 2019; 10():667. PubMed ID: 31275146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.